Metraipolis › archive › dc_b0f2bb703ba5
MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines — Europe PMC PMID:40833497
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40833497
- DOI
- 10.1007/s00018-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T12:03:04.981Z
- SHA-256 of the archived text
f7b7bcc3d6e243840441fce1d643ef533bbb67ea1bdb6aa120ea5e3f876f6a09- Stable URL of this page
https://metraipolis.com/documento/dc_b0f2bb703ba5
How to cite
MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines — Europe PMC PMID:40833497 — Europe PMC (en), https://europepmc.org/article/MED/40833497 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b0f2bb703ba5 (Metraipolis archive dc_b0f2bb703ba5, sha256 f7b7bcc3d6e243840441fce1d643ef533bbb67ea1bdb6aa120ea5e3f876f6a09)
BibTeX
@misc{dcb0f2bb703ba5,
title = {MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines — Europe PMC PMID:40833497},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40833497},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b0f2bb703ba5; sha256 f7b7bcc3d6e243840441fce1d643ef533bbb67ea1bdb6aa120ea5e3f876f6a09},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40833497. Agents can read the archived copy with the MCP tool read_document.